Pre-Bell|Nasdaq Futures Fall More Than 1%; Qualcomm Stock Slides 8%

Tiger Newspress2022-11-03

U.S. stock index futures slipped on Thursday, signaling a fresh round of selloff spurred by worries that the Federal Reserve's rate-hike cycle is far from over as the central bank hinted at smaller rate hikes.

Market Snapshot

At 7:50 a.m. ET, Dow e-minis were down 196 points, or 0.61%, S&P 500 e-minis were down 32 points, or 0.85%, and Nasdaq 100 e-minis were down 123.75 points, or 1.13%.

Pre-Market Movers

Restaurant Brands – The parent of Burger King, Tim Hortons and Popeyes saw its stock rally 4% in premarket trading after the company reported better-than-expected quarterly results. Same-restaurant sales jumped 14%, well above the 8.3% rise predicted by analysts who were surveyed by FactSet.

Under Armour – Under Armour jumped 4.2% in premarket action after the apparel maker reported better-than-expected earnings for its latest quarter, along with revenue that was roughly in line with Street forecasts. The rise comes despite Under Armour cutting its full-year forecast for the impact from a stronger U.S. dollar and higher costs.

Peloton – The fitness equipment maker’s stock tumbled 18.1% in premarket trading after it reported a larger-than-expected quarterly loss and revenue that fell short of analyst predictions. Peloton also issued a weaker-than-expected holiday quarter forecast.

Moderna – The drug maker’s stock slumped 11.9% in premarket action after Moderna reported a quarterly profit of $2.53 per share, well below the consensus estimate of $3.29. The company also cut its annual forecast for Covid-19 vaccine sales.

Qualcomm – Qualcomm slumped 8.3% in the premarket after it gave a worse-than-expected revenue outlook as smartphone shipments slid. The chip maker also reported quarterly revenue and profit that were in line with Wall Street forecasts.

Roku – Roku shares tumbled 18.5% in off-hours trading after the maker of video streaming devices said it expected advertising revenue and device sales to fall in the current quarter. The forecast is weighing on shares despite Roku reporting better-than-expected revenue and a larger-than-expected number of active accounts.

Booking Holdings – Booking Holdings rose by 5.1% in the premarket after the travel services company posted top and bottom line beats for its latest quarter. It also posted an upbeat outlook as travel demand remains strong.

Crown Holdings – Investor Carl Icahn now holds a more than 8% stake in the beverage can maker, according to the Wall Street Journal, and is said to believe the company should buy back more stock and put non-core units up for sale. Crown Holdings rallied 5.5% in the premarket.

eBay – eBay surged 6.7% in premarket trading after the e-commerce company reported better-than-expected results for its latest quarter, boosted by sales of refurbished goods and luxury offerings.

Etsy – Etsy stock spiked 9.3% in the premarket after the online crafts marketplace reported a better-than-expected quarter, saying its business remained strong in a volatile economic environment.

Market News

Peloton Forecasts Weak Revenue for Holiday Quarter

Peloton Interactive Inc on Thursday forecast second-quarter revenue below Wall Street estimates as the company grapples with weak demand for its fitness equipment amid a challenging macro-economic environment.

The exercise bike maker expects current-quarter revenue between $700 million and $725 million, compared with analysts' estimates of $874 million, according to Refinitiv data.

Under Armour Gains After Posting Better-Than-Feared Results

Under Armour traded higher on Thursday after besting consensus marks with its FQ2 earnings report.

Revenue was up 5% on a constant currency basis. North American revenue fell 2% during the quarter and international revenue increased 7% (+16% on a constant currency basis)

Moderna Shares Tumble After Cutting Sales Forecast for COVID Vaccine

Moderna Inc on Thursday cut the annual sales forecast for its COVID-19 vaccine citing short-term supply constraints that would push some vaccine deliveries out to next year, sending its shares down 13% before the bell.

The vaccine maker reported sales of $3.36 billion in the third quarter, missing Wall Street estimates of $3.53 billion. It also did not disclose further details on the supply issues.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
6